133 related articles for article (PubMed ID: 25429644)
1. Predictive factors for pericardial effusion identified by heart dose-volume histogram analysis in oesophageal cancer patients treated with chemoradiotherapy.
Hayashi K; Fujiwara Y; Nomura M; Kamata M; Kojima H; Kohzai M; Sumita K; Tanigawa N
Br J Radiol; 2015 Feb; 88(1046):20140168. PubMed ID: 25429644
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for pericardial effusion in patients with stage I esophageal cancer treated with chemoradiotherapy.
Tamari K; Isohashi F; Akino Y; Suzuki O; Seo Y; Yoshioka Y; Hayashi Y; Nishida T; Takehara T; Mori M; Doki Y; Ogawa K
Anticancer Res; 2014 Dec; 34(12):7389-93. PubMed ID: 25503178
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy.
Wei X; Liu HH; Tucker SL; Wang S; Mohan R; Cox JD; Komaki R; Liao Z
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):707-14. PubMed ID: 18191334
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
Ning MS; Tang L; Gomez DR; Xu T; Luo Y; Huo J; Mouhayar E; Liao Z
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):70-79. PubMed ID: 28816165
[TBL] [Abstract][Full Text] [Related]
5. Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients.
Shirai K; Tamaki Y; Kitamoto Y; Murata K; Satoh Y; Higuchi K; Nonaka T; Ishikawa H; Katoh H; Takahashi T; Nakano T
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1002-7. PubMed ID: 20542385
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patients.
Fukada J; Shigematsu N; Takeuchi H; Ohashi T; Saikawa Y; Takaishi H; Hanada T; Shiraishi Y; Kitagawa Y; Fukuda K
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):487-93. PubMed ID: 23968770
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric predictors of acute haematological toxicity in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy.
Lee J; Lin JB; Sun FJ; Lu KW; Lee CH; Chen YJ; Huang WC; Liu HC; Wu MH
Br J Radiol; 2016 Oct; 89(1066):20160350. PubMed ID: 27556422
[TBL] [Abstract][Full Text] [Related]
8. Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer.
Pao TH; Chang WL; Chiang NJ; Lin CY; Lai WW; Tseng YL; Lin FC
Radiat Oncol; 2020 Feb; 15(1):48. PubMed ID: 32103779
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric predictors of radiation-induced pericardial effusion in esophageal cancer.
Ogino I; Watanabe S; Sakamaki K; Ogino Y; Kunisaki C; Kimura K
Strahlenther Onkol; 2017 Jul; 193(7):552-560. PubMed ID: 28424841
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram.
Takeuchi Y; Murakami Y; Kameoka T; Ochi M; Imano N; Takahashi I; Nishibuchi I; Kimura T; Kawahara D; Saito A; Nagata Y
J Radiat Res; 2020 Mar; 61(2):298-306. PubMed ID: 32052040
[TBL] [Abstract][Full Text] [Related]
11. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for radiation pneumonitis in oesophageal cancer patients treated with chemoradiotherapy without prophylactic nodal irradiation.
Nomura M; Kodaira T; Furutani K; Tachibana H; Tomita N; Goto Y
Br J Radiol; 2012 Jun; 85(1014):813-8. PubMed ID: 22253344
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
[TBL] [Abstract][Full Text] [Related]
14. Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer.
He L; Chapple A; Liao Z; Komaki R; Thall PF; Lin SH
Radiother Oncol; 2016 Oct; 121(1):70-74. PubMed ID: 27562616
[TBL] [Abstract][Full Text] [Related]
15. Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer.
Xue J; Han C; Jackson A; Hu C; Yao H; Wang W; Hayman J; Chen W; Jin J; Kalemkerian GP; Matuzsak M; Jolly S; Kong FS
Radiother Oncol; 2019 Apr; 133():213-219. PubMed ID: 30416046
[TBL] [Abstract][Full Text] [Related]
16. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
Wang SL; Liao Z; Vaporciyan AA; Tucker SL; Liu H; Wei X; Swisher S; Ajani JA; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):692-9. PubMed ID: 16242257
[TBL] [Abstract][Full Text] [Related]
17. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
[TBL] [Abstract][Full Text] [Related]
18. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.
Münch S; Aichmeier S; Hapfelmeier A; Duma MN; Oechsner M; Feith M; Combs SE; Habermehl D
Strahlenther Onkol; 2016 Oct; 192(10):722-9. PubMed ID: 27418129
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for pericardial effusion after chemoradiotherapy for thoracic esophageal cancer-comparison of four-field technique and traditional two opposed fields technique.
Takata N; Kataoka M; Hamamoto Y; Tsuruoka S; Kanzaki H; Uwatsu K; Nagasaki K; Mochizuki T
J Radiat Res; 2018 May; 59(3):291-297. PubMed ID: 29659940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
